494 related articles for article (PubMed ID: 32503171)
21. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
Rayaprolu BM; Strawser JJ; Anyarambhatla G
Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
[TBL] [Abstract][Full Text] [Related]
22. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
Leone F; Cavalli R
Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
[TBL] [Abstract][Full Text] [Related]
23. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
24. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
Kumar A; Pandey AN; Jain SK
Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
[TBL] [Abstract][Full Text] [Related]
25. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
26. Commercialization of nanotechnology.
Hobson DW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):189-202. PubMed ID: 20049790
[TBL] [Abstract][Full Text] [Related]
27. Nanocrystals Technology for Pharmaceutical Science.
Cheng Z; Lian Y; Kamal Z; Ma X; Chen J; Zhou X; Su J; Qiu M
Curr Pharm Des; 2018; 24(21):2497-2507. PubMed ID: 29773056
[TBL] [Abstract][Full Text] [Related]
28. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
[TBL] [Abstract][Full Text] [Related]
30. The Potential of Nanotechnology in Medically Assisted Reproduction.
Remião MH; Segatto NV; Pohlmann A; Guterres SS; Seixas FK; Collares T
Front Pharmacol; 2017; 8():994. PubMed ID: 29375388
[TBL] [Abstract][Full Text] [Related]
31. The interplay between carbon nanomaterials and amyloid fibrils in bio-nanotechnology.
Li C; Mezzenga R
Nanoscale; 2013 Jul; 5(14):6207-18. PubMed ID: 23744243
[TBL] [Abstract][Full Text] [Related]
32. In vitro method for detecting precipitation of parenteral formulations after injection.
Yalkowsky SH; Valvani SC; Johnson BW
J Pharm Sci; 1983 Sep; 72(9):1014-7. PubMed ID: 6631683
[TBL] [Abstract][Full Text] [Related]
33. Advanced Contrast Agents for Multimodal Biomedical Imaging Based on Nanotechnology.
Calle D; Ballesteros P; Cerdán S
Methods Mol Biol; 2018; 1718():441-457. PubMed ID: 29341024
[TBL] [Abstract][Full Text] [Related]
34. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
35. Soft condensed matter in pharmaceutical design.
Paradossi G; Cavalieri F; Chiessi E
Curr Pharm Des; 2006; 12(11):1403-19. PubMed ID: 16611124
[TBL] [Abstract][Full Text] [Related]
36. Achieving "Zero" Defects for Visible Particles in Injectables.
Johns J; Golfetto P; Bush T; Fantozzi G; Shabushnig J; Perry A; Degrazio F; Streich D; Miller J; Soukiassian H; Stanton A; Watson R
PDA J Pharm Sci Technol; 2018; 72(6):640-650. PubMed ID: 30232141
[TBL] [Abstract][Full Text] [Related]
37. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
Asmus LR; Kaufmann B; Melander L; Weiss T; Schwach G; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology versus other techniques in improving drug dissolution.
Kwok PC; Chan HK
Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
[TBL] [Abstract][Full Text] [Related]
39. Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS).
Poklis JL; Mohs AJ; Wolf CE; Poklis A; Peace MR
J Anal Toxicol; 2016 Oct; 40(8):608-616. PubMed ID: 27474362
[TBL] [Abstract][Full Text] [Related]
40. Nanoamorphous drug products - Design and development.
Jog R; Burgess DJ
Int J Pharm; 2018 Dec; 553(1-2):238-260. PubMed ID: 30359685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
